Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe Locations section was updated to include additional recruitment sites across multiple countries, and the total number of locations is shown as 121, indicating expanded geographic accessibility for the trial.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Locations section has been expanded with numerous new study sites across several countries, increasing where participants can enroll, and the page now includes additional navigation links such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference3%

- Check26 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating a small metadata update. Several topic tags were removed (Multiple myeloma, related topics: MedlinePlus Genetics), which appears to be a non-substantive cleanup rather than an update to trial information.SummaryDifference0.1%

- Check47 days agoChange DetectedRecruitment locations were expanded, adding numerous centers across various countries and updating the total number of locations from 39 to 89. The update includes detailed site information and current recruiting statuses to reflect broader access for potential participants.SummaryDifference7%

- Check55 days agoChange DetectedTaoyuan, Taiwan (333) was added as a new site and the total number of locations is now listed as 39; several previously listed sites were removed or had their recruitment statuses updated across multiple countries.SummaryDifference5%

- Check62 days agoChange DetectedThe related topics block loses the 'Multiple myeloma' entry and the 'MedlinePlus Genetics' link, reducing ancillary cross-references while keeping the main study details intact.SummaryDifference0.1%

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.